{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T04:07:41Z","timestamp":1749182861248,"version":"3.41.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Increased incidence of type 1 and type 2 diabetes has been reported in association with the coronavirus disease 2019 pandemic. Little is known about the impact of coronavirus disease 2019 on the presentation of monogenic forms of diabetes. This case report describes diagnosis of the uncommon maturity onset diabetes of the young (neurogenic differentiation factor 1-maturity-onset diabetes of the young) after transient autoimmunity during coronavirus disease 2019 infection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>A 19-year-old Mexican male with autism spectrum disorder was diagnosed with diabetes without ketoacidosis during metabolic screening laboratory testing. He tested positive for coronavirus disease 2019 with no respiratory symptoms. His hemoglobin A1c was 14.2%, and had elevated islet-antigen 2 antibody. His blood glucose responded rapidly to initial dietary reduction in carbohydrate intake without insulin initiation, with subsequent improvement in hemoglobin A1c to 7.4% 2 months later. Then, 2 years after diagnosis, his hemoglobin A1c was 6.0%, and repeat antibody testing was negative. He was taking lisinopril for microalbuminuria, but required no medications for glucose control. Genetic testing identified a variant of <jats:italic>NEUR<\/jats:italic>\n              <jats:italic>OD<\/jats:italic>\n              <jats:italic>1<\/jats:italic> c.514C\u2009&gt;\u2009T, p.(Leu172Phe). His mother who was subsequently diagnosed with diabetes, underwent targeted variant testing and was found to have the same neurogenic differentiation factor 1 variant.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Coronavirus disease 2019 possibly triggered transient autoimmunity, leading to the diagnosis of neurogenic differentiation factor 1-maturity-onset diabetes of the young diabetes. This is also the first description of the clinical features associated with this particular neurogenic differentiation factor 1 variant.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13256-025-05327-7","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T13:35:20Z","timestamp":1749130520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transient islet-antigen 2 positivity at diagnosis of diabetes during COVID-19 infection in an adolescent with a NEUROD1 variant: a case report"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2423-8318","authenticated-orcid":false,"given":"Jennifer K.","family":"Yee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seerat","family":"Anand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Sanabria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine S.","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"issue":"6","key":"5327_CR1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.21281","volume":"6","author":"D D'Souza","year":"2023","unstructured":"D\u2019Souza D, Empringham J, Pechlivanoglou P, Uleryk EM, Cohen E, Shulman R. Incidence of diabetes in children and adolescents during the COVID-19 pandemic: a systematic review and meta-analysis. JAMA Netw Open. 2023;6(6): e2321281.","journal-title":"JAMA Netw Open"},{"issue":"23","key":"5327_CR2","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1001\/jama.2023.8674","volume":"329","author":"A Weiss","year":"2023","unstructured":"Weiss A, Donnachie E, Beyerlein A, Ziegler AG, Bonifacio E. Type 1 diabetes incidence and risk in children with a diagnosis of COVID-19. JAMA. 2023;329(23):2089\u201391.","journal-title":"JAMA"},{"key":"5327_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jpeds.2022.08.010","volume":"251","author":"SN Magge","year":"2022","unstructured":"Magge SN, Wolf RM, Pyle L, Brown EA, Benavides VC, Bianco ME, et al. The coronavirus disease 2019 pandemic is associated with a substantial rise in frequency and severity of presentation of youth-onset type 2 diabetes. J Pediatr. 2022;251:51-9.e2.","journal-title":"J Pediatr"},{"key":"5327_CR4","volume-title":"Endotext","author":"R Naylor","year":"2000","unstructured":"Naylor R, Phillipson N, et al. Diagnosis and clinical management of monogenic diabetes. In: Feingold KRAB, Blackman MR, et al., editors. Endotext. South Dartmouth: MDText.com Inc; 2000."},{"issue":"3","key":"5327_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/15500","volume":"23","author":"MT Malecki","year":"1999","unstructured":"Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, Orban T, et al. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet. 1999;23(3):323\u20138.","journal-title":"Nat Genet"},{"issue":"3","key":"5327_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11892-019-1130-9","volume":"19","author":"Y Horikawa","year":"2019","unstructured":"Horikawa Y, Enya M. Genetic dissection and clinical features of MODY6 (NEUROD1-MODY). Curr Diab Rep. 2019;19(3):12.","journal-title":"Curr Diab Rep"},{"issue":"3","key":"5327_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/humu.22932","volume":"37","author":"X Liu","year":"2016","unstructured":"Liu X, Wu C, Li C, Boerwinkle E. dbNSFP v3.0: a one-stop database of functional predictions and annotations for human nonsynonymous and splice-site SNVs. Hum Mutat. 2016;37(3):235\u201341.","journal-title":"Hum Mutat"},{"key":"5327_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155330","volume":"137","author":"H Lai","year":"2022","unstructured":"Lai H, Yang M, Sun M, Pan B, Wang Q, Wang J, et al. Risk of incident diabetes after COVID-19 infection: a systematic review and meta-analysis. Metabolism. 2022;137: 155330.","journal-title":"Metabolism"},{"issue":"9","key":"5327_CR9","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.2337\/db10-0011","volume":"59","author":"O Rubio-Cabezas","year":"2010","unstructured":"Rubio-Cabezas O, Minton JA, Kantor I, Williams D, Ellard S, Hattersley AT. Homozygous mutations in NEUROD1 are responsible for a novel syndrome of permanent neonatal diabetes and neurological abnormalities. Diabetes. 2010;59(9):2326\u201331.","journal-title":"Diabetes"},{"issue":"1","key":"5327_CR10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12902-021-00864-w","volume":"21","author":"L Brodosi","year":"2021","unstructured":"Brodosi L, Baracco B, Mantovani V, Pironi L. NEUROD1 mutation in an Italian patient with maturity onset diabetes of the young 6: a case report. BMC Endocr Disord. 2021;21(1):202.","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"5327_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/pedi.12553","volume":"19","author":"Y Horikawa","year":"2018","unstructured":"Horikawa Y, Enya M, Mabe H, Fukushima K, Takubo N, Ohashi M, et al. NEUROD1-deficient diabetes (MODY6): identification of the first cases in Japanese and the clinical features. Pediatr Diabetes. 2018;19(2):236\u201342.","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"5327_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12920-020-0669-2","volume":"13","author":"JS Dron","year":"2020","unstructured":"Dron JS, Wang J, McIntyre AD, Iacocca MA, Robinson JF, Ban MR, et al. Six years\u2019 experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias. BMC Med Genom. 2020;13(1):23.","journal-title":"BMC Med Genom"},{"key":"5327_CR13","doi-asserted-by":"publisher","first-page":"101783","DOI":"10.1016\/j.eclinm.2022.101783","volume":"56","author":"R Chang","year":"2023","unstructured":"Chang R, Yen-Ting Chen T, Wang S-I, Hung Y-M, Chen H-Y, Wei C-CJ. Risk of autoimmune diseases in patients with COVID-19: a retrospective cohort study. eClinicalMedicine. 2023;56:101783.","journal-title":"eClinicalMedicine"},{"issue":"6","key":"5327_CR14","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/s42255-021-00407-6","volume":"3","author":"L Montefusco","year":"2021","unstructured":"Montefusco L, Ben Nasr M, D\u2019Addio F, Loretelli C, Rossi A, Pastore I, et al. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab. 2021;3(6):774\u201385.","journal-title":"Nat Metab"},{"issue":"8","key":"5327_CR15","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.2337\/diacare.24.8.1438","volume":"24","author":"S Yamada","year":"2001","unstructured":"Yamada S, Motohashi Y, Yanagawa T, Maruyama T, Kasuga A, Hirose H, et al. NeuroD\/beta2 gene G\u2013>A polymorphism may affect onset pattern of type 1 diabetes in Japanese. Diabetes Care. 2001;24(8):1438\u201341.","journal-title":"Diabetes Care"},{"issue":"1","key":"5327_CR16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1515\/jpem-2022-0356","volume":"36","author":"J M\u00fchrer","year":"2023","unstructured":"M\u00fchrer J, Lang-Muritano M, Lehmann R, Blouin JL, Schwitzgebel VM. Atypical familial diabetes associated with a novel NEUROD1 nonsense variant. J Pediatr Endocrinol Metab. 2023;36(1):101\u20134.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"5327_CR17","doi-asserted-by":"publisher","first-page":"1292073","DOI":"10.3389\/fgene.2023.1292073","volume":"14","author":"A Bawatneh","year":"2023","unstructured":"Bawatneh A, Darwish A, Eideh H, Darwish HM. Identification of gene mutations associated with type 1 diabetes by next-generation sequencing in affected Palestinian families. Front Genet. 2023;14:1292073.","journal-title":"Front Genet"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05327-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05327-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05327-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T13:35:21Z","timestamp":1749130521000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-025-05327-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5327"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05327-7","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"assertion":[{"value":"29 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This is not a research study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors state no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"266"}}